These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8872295)

  • 1. Neurons and receptors in the rostroventrolateral medulla mediating the antihypertensive actions of drugs acting at imidazoline receptors.
    Reis DJ
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S11-18. PubMed ID: 8872295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The imidazoline receptor in control of blood pressure by clonidine and allied drugs.
    Reis DJ; Piletz JE
    Am J Physiol; 1997 Nov; 273(5):R1569-71. PubMed ID: 9374795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.
    Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
    Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prototypical imidazoline-1 receptor ligand moxonidine activates alpha2-adrenoceptors in bulbospinal neurons of the RVL.
    Hayar A; Guyenet PG
    J Neurophysiol; 2000 Feb; 83(2):766-76. PubMed ID: 10669492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between imidazoline and alpha2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents.
    Head GA; Chan CK; Burke SL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):163-9. PubMed ID: 9851565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
    Chan CK; Sannajust F; Head GA
    J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of the effects of intramedullary monoamine neurotoxins on the hypotensive action of moxonidine and on immunodetected imidazoline and alpha 2-receptor proteins.
    Head GA; Chan CK; Zhu H; Piletz JE
    Ann N Y Acad Sci; 1999 Jun; 881():300. PubMed ID: 10415930
    [No Abstract]   [Full Text] [Related]  

  • 16. Responsiveness of α2-adrenoceptor/I1-imidazoline receptor in the rostral ventrolateral medulla to cardiovascular regulation is enhanced in conscious spontaneously hypertensive rat.
    Yamazato M; Nakamoto M; Sakima A; Yamazato Y; Takishita S; Ohya Y
    Clin Exp Hypertens; 2019; 41(3):255-262. PubMed ID: 29764227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of I(1)-imidazoline receptors and alpha2-adrenoceptors in hemodynamic effects of moxonidine administration into the rostroventrolateral medulla.
    Khokhlova ON; Murashev AN; Medvedev OS
    Bull Exp Biol Med; 2001 Apr; 131(4):336-9. PubMed ID: 11550020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central imidazoline receptors and centrally acting anti-hypertensive agents.
    Head GA; Burke SL; Chan CK
    Clin Exp Hypertens; 1997; 19(5-6):591-605. PubMed ID: 9247741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazoline antihypertensive drugs: a critical review on their mechanism of action.
    Szabo B
    Pharmacol Ther; 2002 Jan; 93(1):1-35. PubMed ID: 11916539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.